The drug discovery informatics market is predicted to grow from $3.77 billion in 2024 to $6.06 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%, according to analysts ResearchAndMarkets.com. The recent growth in the market is attributed to advancements in genomics and proteomics, the escalating complexity of drug targets, progress in structural […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!